Vivani Medical VANI Business Segments
| FY'25 | FY'24 | ||
|---|---|---|---|
| Net Income Loss by Business | |||
| Biopharm Division | -$24.15M-13.6% | -$21.26M-4.9% | |
| Neurostimulation Division | -$2.51M-12.3% | -$2.23M+58.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Vivani Medical break its business down?
- Vivani Medical (VANI) reports net income loss by business across 3 parts — Biopharm Division, Neuromodulation Division and Neurostimulation Division. Each is extracted from the segment footnotes and tracked over time.
- Where does Vivani Medical's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Vivani Medical's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.